• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

程序性细胞死亡配体 1(PD-L)有助于调控皮肤利什曼病中的 CD4 效应 T 细胞和调节性 T 细胞。

Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4 T Effector and Regulatory T Cells in Cutaneous Leishmaniasis.

机构信息

Protozoa Immunology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.

Department of Natural Sciences, University of Pernambuco, Garanhuns, Brazil.

出版信息

Front Immunol. 2020 Oct 22;11:574491. doi: 10.3389/fimmu.2020.574491. eCollection 2020.

DOI:10.3389/fimmu.2020.574491
PMID:33193363
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7642203/
Abstract

Cutaneous Leishmaniasis (CL) affects up to one million people every year and treatments are costly and toxic. The regulation of the host immune response is complex and the knowledge of how CD4 T cells are activated and maintained during infection is still limited. Current therapies aim to target programmed cell death (PD)-1 and programmed cell death ligand (PD-L)-1 in order to boost T cell activity. However, the role of the PD-1/PD-L1 axis during infection is still unclear. In this study, we found that patients with active and post-treatment CL displayed different subsets of CD4PD-1 T cells. Accordingly, infected mice upregulated PD-1 on activated CD4 T effector cells and PD-L1 on resident macrophages and infiltrating monocytes at the site of infection. infected mice expressed lower levels of MHCII and higher levels of CD206 on macrophages and monocytes and, more importantly, the lack of PD-L1 contributed to a reduced frequency of CD4Ly6C T effector cells and an increase of CD4Foxp3 regulatory T cells at the site of infection and in draining lymph nodes. Additionally, the lack of PD-L1 was associated with lower production of IL-27 by infiltrating monocytes and lower levels of the Th1 cytokines IFN-γ and TNF-α produced by CD4 T effector cells. mice initially exhibited larger lesions despite having a similar parasite load. Our results describe for the first time how the interruption of the PD-1/PD-L1 axis influences the immune response against CL and suggests that this axis regulates the balance between CD4Ly6C T effector cells and CD4Foxp3 regulatory T cells.

摘要

皮肤利什曼病(CL)每年影响多达 100 万人,治疗费用昂贵且具有毒性。宿主免疫反应的调节非常复杂,人们对 CD4 T 细胞在感染过程中如何被激活和维持的了解仍然有限。目前的治疗方法旨在针对程序性细胞死亡(PD)-1 和程序性细胞死亡配体(PD-L)-1,以增强 T 细胞的活性。然而,PD-1/PD-L1 轴在感染过程中的作用仍不清楚。在这项研究中,我们发现活动性和治疗后 CL 患者显示出不同的 CD4PD-1 T 细胞亚群。相应地,感染小鼠在感染部位上调了活化的 CD4 T 效应细胞上的 PD-1 和驻留巨噬细胞和浸润单核细胞上的 PD-L1。感染小鼠在巨噬细胞和单核细胞上表达较低水平的 MHCII 和较高水平的 CD206,更重要的是,缺乏 PD-L1 导致感染部位和引流淋巴结中 CD4Ly6C T 效应细胞的频率降低和 CD4Foxp3 调节性 T 细胞的增加。此外,缺乏 PD-L1 与浸润单核细胞中 IL-27 的产生减少以及 CD4 T 效应细胞中产生的 Th1 细胞因子 IFN-γ和 TNF-α水平降低有关。尽管寄生虫载量相似,但缺乏 PD-L1 的 小鼠最初表现出更大的病变。我们的研究结果首次描述了 PD-1/PD-L1 轴如何影响针对 CL 的免疫反应,并表明该轴调节 CD4Ly6C T 效应细胞和 CD4Foxp3 调节性 T 细胞之间的平衡。

相似文献

1
Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4 T Effector and Regulatory T Cells in Cutaneous Leishmaniasis.程序性细胞死亡配体 1(PD-L)有助于调控皮肤利什曼病中的 CD4 效应 T 细胞和调节性 T 细胞。
Front Immunol. 2020 Oct 22;11:574491. doi: 10.3389/fimmu.2020.574491. eCollection 2020.
2
Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB/c mice reduce parasite load.抗 PD-1 和抗 PD-L1 免疫疗法可降低感染利什曼原虫的 BALB/c 小鼠的寄生虫载量。
Sci Rep. 2019 Dec 30;9(1):20275. doi: 10.1038/s41598-019-56336-8.
3
TNF contributes to T-cell exhaustion in chronic L. mexicana infections of mice through PD-L1 up-regulation.TNF 通过上调 PD-L1 促进慢性 L. mexicana 感染小鼠 T 细胞耗竭。
Cell Immunol. 2020 Dec;358:104196. doi: 10.1016/j.cellimm.2020.104196. Epub 2020 Sep 14.
4
PD-1 and PD-L1 expression on T-cell subsets in women with unexplained recurrent pregnancy losses.PD-1 和 PD-L1 在不明原因复发性妊娠丢失妇女 T 细胞亚群上的表达。
Am J Reprod Immunol. 2020 May;83(5):e13230. doi: 10.1111/aji.13230. Epub 2020 Mar 23.
5
Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation.程序性细胞死亡受体 1 通路的损伤会增加动脉粥样硬化病变的发展和炎症。
Arterioscler Thromb Vasc Biol. 2011 May;31(5):1100-7. doi: 10.1161/ATVBAHA.111.224709. Epub 2011 Mar 10.
6
Nocardia Rubra Cell Wall Skeleton Up-Regulates T Cell Subsets and Inhibits PD-1/PD-L1 Pathway to Promote Local Immune Status of Patients With High-Risk Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia.红色诺卡氏菌细胞壁骨架上调T细胞亚群并抑制PD-1/PD-L1通路,以促进高危型人乳头瘤病毒感染和宫颈上皮内瘤变患者的局部免疫状态。
Front Immunol. 2021 Jan 20;11:612547. doi: 10.3389/fimmu.2020.612547. eCollection 2020.
7
Parasites Drive PD-L1 Expression in Mice and Human Neutrophils With Suppressor Capacity.寄生虫驱动 PD-L1 在具有抑制能力的小鼠和人中性粒细胞中的表达。
Front Immunol. 2021 Jun 15;12:598943. doi: 10.3389/fimmu.2021.598943. eCollection 2021.
8
PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1.PD-L1 增强了实验性中风后小鼠的中枢神经系统炎症和梗死体积,与 PD-1 相反。
J Neuroinflammation. 2013 Sep 9;10:111. doi: 10.1186/1742-2094-10-111.
9
Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.PD-1 和 CTLA-4 的双重阻断联合肿瘤疫苗可有效恢复肿瘤中 T 细胞的排斥功能。
Cancer Res. 2013 Jun 15;73(12):3591-603. doi: 10.1158/0008-5472.CAN-12-4100. Epub 2013 Apr 30.
10
CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection.CD4+CD25+调节性T细胞在亚马逊利什曼原虫感染期间抑制致病性反应。
J Immunol. 2005 Jun 1;174(11):7147-53. doi: 10.4049/jimmunol.174.11.7147.

引用本文的文献

1
Monoclonal antibodies: From magic bullet to precision weapon.单克隆抗体:从“魔弹”到“精准武器”。
Mol Biomed. 2024 Oct 11;5(1):47. doi: 10.1186/s43556-024-00210-1.
2
Intralesional gene expression profile of JAK-STAT signaling pathway and associated cytokines in infected patients.感染患者 JAK-STAT 信号通路及其相关细胞因子的瘤内基因表达谱。
Front Immunol. 2024 Sep 19;15:1436029. doi: 10.3389/fimmu.2024.1436029. eCollection 2024.
3
CXCR5 and TIM-3 expressions define distinct exhausted T cell subsets in experimental cutaneous infection with .

本文引用的文献

1
Granzyme B Inhibition by Tofacitinib Blocks the Pathology Induced by CD8 T Cells in Cutaneous Leishmaniasis.托法替尼抑制颗粒酶 B 阻断 CD8 T 细胞诱导的皮肤利什曼病病理。
J Invest Dermatol. 2021 Mar;141(3):575-585. doi: 10.1016/j.jid.2020.07.011. Epub 2020 Jul 30.
2
Antileishmanial Effects of Synthetic PIb Analogs Derived from the Entamoeba histolytica Lipopeptidephosphoglycan.源自溶组织内阿米巴脂肽磷酸聚糖的合成PIb类似物的抗利什曼原虫作用
Antimicrob Agents Chemother. 2020 Jun 23;64(7). doi: 10.1128/AAC.00161-20.
3
T-cell exhaustion in HIV infection.
CXCR5 和 TIM-3 的表达在实验性皮肤感染 中定义了不同的耗竭性 T 细胞亚群。
Front Immunol. 2023 Aug 25;14:1231836. doi: 10.3389/fimmu.2023.1231836. eCollection 2023.
4
The cytokine/chemokine response in /HIV infection and co-infection.HIV感染及合并感染中的细胞因子/趋化因子反应
Heliyon. 2023 Apr 1;9(4):e15055. doi: 10.1016/j.heliyon.2023.e15055. eCollection 2023 Apr.
5
Resveratrol Enhances the Radiosensitivity by Inducing DNA Damage and Antitumor Immunity in a Glioblastoma Rat Model under 3 T MRI Monitoring.白藜芦醇在3T MRI监测下通过诱导DNA损伤和抗肿瘤免疫增强胶质母细胞瘤大鼠模型的放射敏感性。
J Oncol. 2022 Oct 13;2022:9672773. doi: 10.1155/2022/9672773. eCollection 2022.
6
Characterization of a novel cysteine protease inhibitor in migratory larvae and its role in regulating mice immune cell response.鉴定迁移幼虫中的一种新型半胱氨酸蛋白酶抑制剂及其在调节小鼠免疫细胞反应中的作用。
Front Immunol. 2022 Aug 29;13:894820. doi: 10.3389/fimmu.2022.894820. eCollection 2022.
7
Role of the PD-1/PD-L1 Pathway in Experimental Infection and Potential Therapeutic Options.PD-1/PD-L1 通路在实验性感染中的作用及潜在治疗选择。
Front Immunol. 2022 Jun 23;13:866120. doi: 10.3389/fimmu.2022.866120. eCollection 2022.
8
Exhausted PD-1 TOX CD8 T Cells Arise Only in Long-Term Experimental Infection.耗竭的 PD-1 毒性 CD8 T 细胞仅在长期实验性感染中出现。
Front Immunol. 2022 Jun 3;13:866179. doi: 10.3389/fimmu.2022.866179. eCollection 2022.
9
Monoclonal Antibodies for Protozoan Infections: A Future Reality or a Utopic Idea?用于原生动物感染的单克隆抗体:是未来的现实还是乌托邦式的想法?
Front Med (Lausanne). 2021 Oct 12;8:745665. doi: 10.3389/fmed.2021.745665. eCollection 2021.
10
Total Glucosides of Paeony Ameliorate Pristane-Induced Lupus Nephritis by Inducing PD-1 ligands Macrophages Activating IL-4/STAT6/PD-L2 Signaling.白芍总苷通过诱导 PD-1 配体巨噬细胞激活 IL-4/STAT6/PD-L2 信号通路改善马兜铃酸诱导的狼疮肾炎。
Front Immunol. 2021 Jul 5;12:683249. doi: 10.3389/fimmu.2021.683249. eCollection 2021.
HIV 感染中的 T 细胞耗竭。
Immunol Rev. 2019 Nov;292(1):149-163. doi: 10.1111/imr.12823.
4
Cutaneous Leishmaniasis: The Complexity of Host's Effective Immune Response against a Polymorphic Parasitic Disease.皮肤利什曼病:宿主对多态寄生虫病的有效免疫反应的复杂性。
J Immunol Res. 2019 Dec 1;2019:2603730. doi: 10.1155/2019/2603730. eCollection 2019.
5
PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways.PD-L1:CD80 顺式二聚体激活共刺激受体 CD28,同时抑制抑制性 PD-1 和 CTLA-4 通路。
Immunity. 2019 Dec 17;51(6):1059-1073.e9. doi: 10.1016/j.immuni.2019.11.003. Epub 2019 Nov 19.
6
Granzyme B Produced by Natural Killer Cells Enhances Inflammatory Response and Contributes to the Immunopathology of Cutaneous Leishmaniasis.自然杀伤细胞产生的颗粒酶 B 增强炎症反应,并有助于皮肤利什曼病的免疫病理学。
J Infect Dis. 2020 Mar 2;221(6):973-982. doi: 10.1093/infdis/jiz538.
7
Mechanisms regulating PD-L1 expression on tumor and immune cells.调控肿瘤细胞和免疫细胞 PD-L1 表达的机制。
J Immunother Cancer. 2019 Nov 15;7(1):305. doi: 10.1186/s40425-019-0770-2.
8
Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis.利什曼病疫苗及其开发对美国皮肤利什曼病的影响。
Hum Vaccin Immunother. 2020 Apr 2;16(4):919-930. doi: 10.1080/21645515.2019.1678998. Epub 2019 Nov 11.
9
IL-27 and TCR Stimulation Promote T Cell Expression of Multiple Inhibitory Receptors.白细胞介素-27与T细胞受体刺激促进多种抑制性受体的T细胞表达
Immunohorizons. 2019 Jan 15;3(1):13-25. doi: 10.4049/immunohorizons.1800083.
10
PD-1 regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer.PD-1 阻断扩增的 PD-1 调节性 T 细胞促进癌症的过度进展。
Proc Natl Acad Sci U S A. 2019 May 14;116(20):9999-10008. doi: 10.1073/pnas.1822001116. Epub 2019 Apr 26.